Jon Arizti Sanz*, Garrett Dunlap*, Nicholas Nolan*, and Colin O’Leary
Edited by Riley Drake and Friederike M. C. Benning
Article | Aug. 29 2022
*Email: email@example.com, firstname.lastname@example.org, email@example.com
- Recent advances in synthetic biology have dramatically changed the biosecurity landscape in terms of potential agents and parties involved
- Biological threat attribution technology is developing and has seen relative success, but is limited by its enforceability
- International efforts have provided a source of threat mitigation, but gaps in compliance verification along with the rapid pace of technological development, pose ongoing issues to these agreements
This MIT Science Policy Review article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/ by/4.0/.